Treatment of Chemotherapy Refractory EGFR(Epidermal Growth Factor Receptor) Positive Advanced Solid Tumors (CART-EGFR)

NCT01869166 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Advanced EGFR-positive Solid Tumors

Interventions

BIOLOGICAL: CART-EGFR

Sponsor

Chinese PLA General Hospital